In last trading session, Clover Health Investments Corp (NASDAQ:CLOV) saw 19.93 million shares changing hands with its beta currently measuring 2.04. Company’s recent per share price level of $3.67 trading at -$0.68 or -15.63% at ring of the bell on the day assigns it a market valuation of $1.83B. That closing price of CLOV’s stock is at a discount of -28.34% from its 52-week high price of $4.71 and is indicating a premium of 83.38% from its 52-week low price of $0.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.4 million shares which gives us an average trading volume of 9.33 million if we extend that period to 3-months.

For Clover Health Investments Corp (CLOV), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 2.33. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Clover Health Investments Corp (NASDAQ:CLOV) trade information

Upright in the red during last session for losing -15.63%, in the last five days CLOV remained trading in the red while hitting it’s week-highest on Wednesday, 11/06/24 when the stock touched $3.67 price level, adding 18.44% to its value on the day. Clover Health Investments Corp’s shares saw a change of 285.46% in year-to-date performance and have moved -10.92% in past 5-day. Clover Health Investments Corp (NASDAQ:CLOV) showed a performance of -6.14% in past 30-days. Number of shares sold short was 15.75 million shares which calculate 1.86 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 2.15 to the stock, which implies a fall of -70.7% to its current value. Analysts have been projecting 1.8 as a low price target for the stock while placing it at a high target of 2.5. It follows that stock’s current price would jump 50.95% in reaching the projected high whereas dropping to the targeted low would mean a gain of 50.95% for stock’s current value.

Clover Health Investments Corp (CLOV) estimates and forecasts

Statistics highlight that Clover Health Investments Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company added 325.11% of value to its shares in past 6 months, showing an annual growth rate of 68.29% while that of industry is 26.70. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -585.84% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 73.31% while estimates for its earnings growth in next 5 years are of 19.10%.

Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders

Insiders are in possession of 5.41% of company’s total shares while institution are holding 18.67 percent of that, with stock having share float percentage of 19.73%. Investors also watch the number of corporate investors in a company very closely, which is 18.67% institutions for Clover Health Investments Corp that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at CLOV for having 17.35 million shares of worth $21.33 million. And as of 2024-06-30, it was holding 3.5662 of the company’s outstanding shares.

The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 11.27 million shares on 2024-06-30. The number of shares represents firm’s hold over 2.3176 of outstanding shares, having a total worth of $13.86 million.